Annual SGA
$35.80 M
+$15.80 M+78.96%
December 31, 2023
Summary
- As of February 7, 2025, CRMD annual SGA is $35.80 million, with the most recent change of +$15.80 million (+78.96%) on December 31, 2023.
- During the last 3 years, CRMD annual SGA has risen by +$21.92 million (+157.98%).
- CRMD annual SGA is now at all-time high.
Performance
CRMD SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$13.33 M
-$1.62 M-10.81%
September 30, 2024
Summary
- As of February 7, 2025, CRMD quarterly SGA is $13.33 million, with the most recent change of -$1.62 million (-10.81%) on September 30, 2024.
- Over the past year, CRMD quarterly SGA has dropped by -$50.20 thousand (-0.38%).
- CRMD quarterly SGA is now -11.42% below its all-time high of $15.05 million, reached on March 31, 2024.
Performance
CRMD Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.36 B
-$46.15 M-3.51%
September 30, 2024
Summary
- As of February 7, 2025, CRMD TTM SGA is -$1.36 billion, with the most recent change of -$46.15 million (-3.51%) on September 30, 2024.
- Over the past year, CRMD TTM SGA has dropped by -$1.40 billion (-3902.17%).
- CRMD TTM SGA is now -5273.96% below its all-time high of -$25.33 million.
Performance
CRMD TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CRMD Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +79.0% | -0.4% | -3902.2% |
| 3 y3 years | +158.0% | +139.1% | -6904.3% |
| 5 y5 years | +343.4% | +297.2% | -8918.2% |
CRMD Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +119.0% | -11.4% | +192.8% | -45.2% | at low |
| 5 y | 5-year | at high | +262.9% | -11.4% | +397.8% | -80.4% | at low |
| alltime | all time | at high | +2968.4% | -11.4% | >+9999.0% | -5274.0% | at low |
CorMedix Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $13.33 M(-10.8%) | $56.70 M(+10.8%) |
| Jun 2024 | - | $14.95 M(-0.7%) | $51.18 M(+18.4%) |
| Mar 2024 | - | $15.05 M(+12.5%) | $43.24 M(+20.8%) |
| Dec 2023 | $35.80 M(+79.0%) | $13.38 M(+71.5%) | $35.80 M(+27.9%) |
| Sep 2023 | - | $7.80 M(+11.3%) | $28.00 M(+12.8%) |
| Jun 2023 | - | $7.01 M(-7.9%) | $24.82 M(+8.6%) |
| Mar 2023 | - | $7.61 M(+36.5%) | $22.86 M(+14.3%) |
| Dec 2022 | $20.01 M(+22.4%) | $5.58 M(+20.5%) | $20.01 M(+5.4%) |
| Sep 2022 | - | $4.63 M(-8.4%) | $18.98 M(+4.4%) |
| Jun 2022 | - | $5.05 M(+6.3%) | $18.19 M(+10.3%) |
| Mar 2022 | - | $4.75 M(+4.3%) | $16.50 M(+0.9%) |
| Dec 2021 | $16.35 M(+17.8%) | $4.55 M(+18.7%) | $16.35 M(+4.9%) |
| Sep 2021 | - | $3.84 M(+14.3%) | $15.58 M(+0.9%) |
| Jun 2021 | - | $3.36 M(-27.1%) | $15.44 M(+0.8%) |
| Mar 2021 | - | $4.60 M(+21.4%) | $15.31 M(+10.3%) |
| Dec 2020 | $13.88 M(+40.7%) | $3.79 M(+2.6%) | $13.88 M(+8.7%) |
| Sep 2020 | - | $3.69 M(+14.2%) | $12.77 M(+9.1%) |
| Jun 2020 | - | $3.23 M(+2.1%) | $11.71 M(+6.0%) |
| Mar 2020 | - | $3.17 M(+18.2%) | $11.05 M(+12.0%) |
| Dec 2019 | $9.87 M(+22.2%) | $2.68 M(+1.8%) | $9.87 M(+4.9%) |
| Sep 2019 | - | $2.63 M(+2.3%) | $9.40 M(+7.0%) |
| Jun 2019 | - | $2.57 M(+29.6%) | $8.78 M(+7.7%) |
| Mar 2019 | - | $1.98 M(-10.3%) | $8.16 M(+1.0%) |
| Dec 2018 | $8.07 M(-6.7%) | $2.21 M(+10.0%) | $8.07 M(+3.1%) |
| Sep 2018 | - | $2.01 M(+3.4%) | $7.83 M(+0.3%) |
| Jun 2018 | - | $1.95 M(+2.2%) | $7.81 M(-1.3%) |
| Mar 2018 | - | $1.90 M(-3.3%) | $7.91 M(-8.5%) |
| Dec 2017 | $8.65 M(-2.6%) | $1.97 M(-1.2%) | $8.65 M(-5.1%) |
| Sep 2017 | - | $1.99 M(-2.9%) | $9.12 M(-3.5%) |
| Jun 2017 | - | $2.05 M(-22.3%) | $9.44 M(+0.9%) |
| Mar 2017 | - | $2.64 M(+8.5%) | $9.36 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $8.88 M(-13.5%) | $2.43 M(+5.0%) | $8.77 M(+1.9%) |
| Sep 2016 | - | $2.32 M(+17.8%) | $8.60 M(-6.8%) |
| Jun 2016 | - | $1.97 M(-4.0%) | $9.23 M(-4.0%) |
| Mar 2016 | - | $2.05 M(-9.6%) | $9.62 M(-6.3%) |
| Dec 2015 | $10.26 M(+40.1%) | $2.27 M(-23.1%) | $10.26 M(+7.8%) |
| Sep 2015 | - | $2.95 M(+25.2%) | $9.52 M(+16.7%) |
| Jun 2015 | - | $2.36 M(-12.5%) | $8.16 M(+8.7%) |
| Mar 2015 | - | $2.69 M(+76.7%) | $7.51 M(+2.5%) |
| Dec 2014 | $7.33 M(+110.0%) | $1.52 M(-3.9%) | $7.33 M(+0.0%) |
| Sep 2014 | - | $1.59 M(-6.8%) | $7.33 M(+17.3%) |
| Jun 2014 | - | $1.70 M(-32.2%) | $6.24 M(+14.6%) |
| Mar 2014 | - | $2.51 M(+64.9%) | $5.45 M(+56.2%) |
| Dec 2013 | $3.49 M(+87.9%) | $1.52 M(+202.1%) | $3.49 M(+61.3%) |
| Sep 2013 | - | $504.50 K(-44.5%) | $2.16 M(-10.1%) |
| Jun 2013 | - | $908.70 K(+64.7%) | $2.40 M(+28.4%) |
| Mar 2013 | - | $551.70 K(+179.2%) | $1.87 M(+0.8%) |
| Dec 2012 | $1.86 M(-41.0%) | $197.60 K(-73.5%) | $1.86 M(-15.5%) |
| Sep 2012 | - | $746.70 K(+98.3%) | $2.20 M(-5.6%) |
| Jun 2012 | - | $376.60 K(-29.8%) | $2.33 M(-18.3%) |
| Mar 2012 | - | $536.30 K(-0.5%) | $2.85 M(-9.5%) |
| Dec 2011 | $3.15 M(+4.5%) | $539.20 K(-38.5%) | $3.15 M(-15.3%) |
| Sep 2011 | - | $877.00 K(-2.3%) | $3.72 M(+6.7%) |
| Jun 2011 | - | $898.00 K(+7.6%) | $3.48 M(+8.8%) |
| Mar 2011 | - | $834.50 K(-24.5%) | $3.20 M(+6.2%) |
| Dec 2010 | $3.01 M(+158.2%) | $1.11 M(+72.2%) | $3.01 M(+51.9%) |
| Sep 2010 | - | $642.30 K(+4.0%) | $1.98 M(+17.7%) |
| Jun 2010 | - | $617.80 K(-4.5%) | $1.68 M(+19.6%) |
| Mar 2010 | - | $646.80 K(+745.5%) | $1.41 M(+20.7%) |
| Dec 2009 | $1.17 M | $76.50 K(-77.7%) | $1.17 M(+7.0%) |
| Sep 2009 | - | $343.60 K(+0.6%) | $1.09 M(+46.0%) |
| Jun 2009 | - | $341.40 K(-15.8%) | $746.70 K(+84.2%) |
| Mar 2009 | - | $405.30 K | $405.30 K |
FAQ
- What is CorMedix annual SGA?
- What is the all time high annual SGA for CorMedix?
- What is CorMedix annual SGA year-on-year change?
- What is CorMedix quarterly SGA?
- What is the all time high quarterly SGA for CorMedix?
- What is CorMedix quarterly SGA year-on-year change?
- What is CorMedix TTM SGA?
- What is the all time high TTM SGA for CorMedix?
- What is CorMedix TTM SGA year-on-year change?
What is CorMedix annual SGA?
The current annual SGA of CRMD is $35.80 M
What is the all time high annual SGA for CorMedix?
CorMedix all-time high annual SGA is $35.80 M
What is CorMedix annual SGA year-on-year change?
Over the past year, CRMD annual SGA has changed by +$15.80 M (+78.96%)
What is CorMedix quarterly SGA?
The current quarterly SGA of CRMD is $13.33 M
What is the all time high quarterly SGA for CorMedix?
CorMedix all-time high quarterly SGA is $15.05 M
What is CorMedix quarterly SGA year-on-year change?
Over the past year, CRMD quarterly SGA has changed by -$50.20 K (-0.38%)
What is CorMedix TTM SGA?
The current TTM SGA of CRMD is -$1.36 B
What is the all time high TTM SGA for CorMedix?
CorMedix all-time high TTM SGA is -$25.33 M
What is CorMedix TTM SGA year-on-year change?
Over the past year, CRMD TTM SGA has changed by -$1.40 B (-3902.17%)